Senior insider sale
THERAVANCE BIOPHARMA, INC. — senior position signals high conviction
$809.3K
45K shares
What this filing means
BROSHY ERAN plans to sell 45K shares of THERAVANCE BIOPHARMA, INC. valued at approximately $809.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/12/2025ACC: 0001950047-25-008708
45K
Shares to sell
$809.3K
Approx. market value
45K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months5
Stock Option Exercise
Cash
11/11/2025
14KRestricted Stock
Not Applicable
4/26/2023
9.85KRestricted Stock
Not Applicable
4/26/2022
9.83KRestricted Stock
Not Applicable
4/27/2021
6.63KRestricted Stock
Not Applicable
4/30/2019
4.68KTotal acquired45K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/11/2025 | Stock Option Exercise Cash | 14K | — |
4/26/2023 | Restricted Stock Not Applicable | 9.85K | — |
4/26/2022 | Restricted Stock Not Applicable | 9.83K | — |
4/27/2021 | Restricted Stock Not Applicable | 6.63K | — |
4/30/2019 | Restricted Stock Not Applicable | 4.68K | — |
| Total | 45K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
45K
Market value
$809.3K
11/11/2025
Total
Units
45K
Value
$809.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/11/2025 | 45K | $809.3K | NASDAQ | Planned |
| Total | 45K | $809.3K | ||